AbbVie to bolster immunity illness drug pipeline with Landos deal – ET HealthWorld | Pharma
London: AbbVie will buy drug developer Landos Biopharma for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat...
London: AbbVie will buy drug developer Landos Biopharma for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat...
London: The U.S. Food and Drug Administration said on Friday it had granted traditional approval for AbbVie’s “guided missile” cancer therapy, Elahere, for patients with...
By Yadarisa Shabong London: AstraZeneca said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 billion in cash as the...
London: The U.S. Food and Drug Administration on Thursday expanded the use of Bristol Myers Squibb‘s cell therapy, Breyanzi, for a type of slow-growing blood...
By Bhanvi Satija and Sneha S K London: The U.S. Food and Drug Administration‘s staff on Wednesday raised concerns that it was unclear if Johnson...